Pin Oak Investment Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-154
| Closed | -$3K | – | 483 |
|
|
2023
Q3 | $3K | Hold |
154
| – | – | ﹤0.01% | 426 |
|
|
2023
Q2 | $2K | Hold |
154
| – | – | ﹤0.01% | 437 |
|
|
2023
Q1 | $2K | Hold |
154
| – | – | ﹤0.01% | 410 |
|
|
2022
Q4 | $2K | Hold |
154
| – | – | ﹤0.01% | 399 |
|
|
2022
Q3 | $2K | Hold |
154
| – | – | ﹤0.01% | 366 |
|
|
2022
Q2 | $2K | Hold |
154
| – | – | ﹤0.01% | 384 |
|
|
2022
Q1 | $3K | Hold |
154
| – | – | ﹤0.01% | 394 |
|
|
2021
Q4 | $3K | Hold |
154
| – | – | ﹤0.01% | 392 |
|
|
2021
Q3 | $2K | Hold |
154
| – | – | ﹤0.01% | 382 |
|
|
2021
Q2 | $3K | Hold |
154
| – | – | ﹤0.01% | 369 |
|
|
2021
Q1 | $4K | Hold |
154
| – | – | ﹤0.01% | 368 |
|
|
2020
Q4 | $4K | Hold |
154
| – | – | ﹤0.01% | 387 |
|
|
2020
Q3 | $6K | Hold |
154
| – | – | 0.01% | 348 |
|
|
2020
Q2 | $7K | Hold |
154
| – | – | 0.01% | 324 |
|
|
2020
Q1 | $10K | Hold |
154
| – | – | 0.01% | 301 |
|
|
2019
Q4 | $19K | Hold |
154
| – | – | 0.02% | 267 |
|
|
2019
Q3 | $10K | Hold |
154
| – | – | 0.01% | 329 |
|
|
2019
Q2 | $12K | Hold |
154
| – | – | 0.01% | 339 |
|
|
2019
Q1 | $17K | Hold |
154
| – | – | 0.01% | 281 |
|
|
2018
Q4 | $16K | Hold |
154
| – | – | 0.01% | 272 |
|
|
2018
Q3 | $19K | Buy |
+154
| New | +$16.3K | 0.01% | 264 |
|
Pin Oak Investment Advisors's ICPT Position: Q4 2023 in Review
Pin Oak Investment Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 154 shares — an estimated $3K sold.
Pin Oak Investment Advisors first reported a position in ICPT in Q3 2018 and held it in 21 quarters. The position peaked at $19K in Q4 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Pin Oak Investment Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Pin Oak Investment Advisors sold 154 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $3K.
- Pin Oak Investment Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2018 and held it in 21 quarters.
- Pin Oak Investment Advisors's Intercept Pharmaceuticals, Inc. position peaked at $19K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Pin Oak Investment Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.